Literature DB >> 11977871

Discharging older adults with a severe and chronic mental illness in the community.

Nadine Larivière1, Isabelle Gélinas, Barbara Mazer, Beverlea Tallant, Isabelle Paquette.   

Abstract

In recent years, a deinstitutionalization movement has been occurring in Canadian psychiatric institutions. Occupational therapists, experts in evaluating occupational performance, are key contributors to the selection of appropriate community housing environments. This study describes the global functioning, performance in activities of daily living, social behavior, cognitive status, and quality of life of 33 older adults with a severe and chronic mental illness, who were transferred from a psychiatric hospital to community facilities between 1995 and 1998. Evaluations were repeated five times, twice before discharge and three times after the transfer. Participants demonstrated stability in their global, social and ADL functioning over time. In general, participants required occasional intervention for management of social behaviors, moderate assistance in activities of daily living, and were highly satisfied with their community accommodation. The transfer to community settings did not lead to a significant deterioration in the participants' levels of global functioning and quality of life.

Entities:  

Mesh:

Year:  2002        PMID: 11977871     DOI: 10.1177/000841740206900203

Source DB:  PubMed          Journal:  Can J Occup Ther        ISSN: 0008-4174            Impact factor:   1.614


  2 in total

1.  Postdischarge treatment costs following closure of a state geropsychiatric ward: comparison of 2 levels of community care.

Authors:  Clarke St Dennis; Michael Hendryx; Anne-Lenora Henriksen; Stephen M Setter; Brandy Singer
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

Review 2.  Process of Deinstitutionalization of Aging Individuals With Severe and Disabling Mental Disorders: A Review.

Authors:  Samira Salime; Christophe Clesse; Alexis Jeffredo; Martine Batt
Journal:  Front Psychiatry       Date:  2022-03-24       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.